Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb13
|
ENSMUSG00000049604.3 | homeobox B13 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_96194126_96195463 | Hoxb13 | 478 | 0.689873 | 0.40 | 1.6e-03 | Click! |
chr11_96199669_96200892 | Hoxb13 | 5964 | 0.114463 | 0.39 | 1.8e-03 | Click! |
chr11_96202439_96204563 | Hoxb13 | 9185 | 0.104941 | 0.37 | 3.2e-03 | Click! |
chr11_96190174_96190661 | Hoxb13 | 3899 | 0.132931 | 0.37 | 3.4e-03 | Click! |
chr11_96193579_96194050 | Hoxb13 | 502 | 0.671958 | 0.35 | 6.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_115346333_115347310 | 14.82 |
Gm47891 |
predicted gene, 47891 |
64620 |
0.13 |
chr6_52224853_52226609 | 14.55 |
Hoxa9 |
homeobox A9 |
458 |
0.51 |
chr6_52223549_52223812 | 14.37 |
Hoxa7 |
homeobox A7 |
1826 |
0.1 |
chr3_5222045_5223052 | 14.07 |
Zfhx4 |
zinc finger homeodomain 4 |
1043 |
0.46 |
chr11_19423801_19424837 | 13.17 |
Gm12026 |
predicted gene 12026 |
40634 |
0.18 |
chr13_15466077_15468087 | 13.00 |
Gli3 |
GLI-Kruppel family member GLI3 |
3102 |
0.22 |
chr2_74685101_74685588 | 12.80 |
Gm28309 |
predicted gene 28309 |
1898 |
0.11 |
chr10_103026340_103027824 | 12.71 |
Alx1 |
ALX homeobox 1 |
1545 |
0.39 |
chr6_52211753_52213405 | 12.65 |
Hoxa3 |
homeobox A3 |
536 |
0.36 |
chr6_52223255_52223534 | 12.64 |
Hoxa7 |
homeobox A7 |
1540 |
0.13 |
chr15_102983048_102983651 | 12.44 |
Hoxc9 |
homeobox C9 |
6317 |
0.08 |
chr3_86543379_86544222 | 11.81 |
Lrba |
LPS-responsive beige-like anchor |
1767 |
0.38 |
chr6_52237474_52238484 | 11.74 |
Hoxa10 |
homeobox A10 |
2816 |
0.08 |
chr6_52244514_52245126 | 11.72 |
Hoxa11os |
homeobox A11, opposite strand |
423 |
0.51 |
chr11_96292706_96294113 | 11.44 |
Hoxb6 |
homeobox B6 |
933 |
0.29 |
chr1_163308490_163310681 | 11.28 |
Gm37644 |
predicted gene, 37644 |
518 |
0.77 |
chr15_102954902_102955460 | 11.09 |
Hoxc11 |
homeobox C11 |
754 |
0.42 |
chr14_118362932_118364036 | 11.02 |
Gm26791 |
predicted gene, 26791 |
248 |
0.89 |
chr3_86544323_86545126 | 10.74 |
Lrba |
LPS-responsive beige-like anchor |
2031 |
0.33 |
chr1_19215607_19218714 | 10.63 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr9_60562470_60563218 | 9.72 |
Gm17853 |
predicted gene, 17853 |
14649 |
0.13 |
chr18_84082718_84083733 | 9.69 |
Tshz1 |
teashirt zinc finger family member 1 |
1850 |
0.29 |
chr18_54125378_54126373 | 9.28 |
Gm8594 |
predicted gene 8594 |
94567 |
0.09 |
chr6_94695739_94697689 | 9.07 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
3423 |
0.29 |
chr2_74689028_74690409 | 8.96 |
Hoxd10 |
homeobox D10 |
2206 |
0.09 |
chr6_52216788_52218128 | 8.85 |
Hoxa7 |
homeobox A7 |
6 |
0.91 |
chr11_96347886_96350398 | 8.77 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chr3_131738069_131738640 | 8.64 |
Gm29865 |
predicted gene, 29865 |
21451 |
0.25 |
chr12_33960516_33961726 | 8.60 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
3450 |
0.27 |
chr6_52257098_52257896 | 8.56 |
9530018H14Rik |
RIKEN cDNA 9530018H14 gene |
37 |
0.92 |
chr5_21543417_21545108 | 8.42 |
Lrrc17 |
leucine rich repeat containing 17 |
699 |
0.68 |
chr6_21217917_21219303 | 8.33 |
Kcnd2 |
potassium voltage-gated channel, Shal-related family, member 2 |
3107 |
0.33 |
chr1_170109295_170110836 | 8.31 |
Ddr2 |
discoidin domain receptor family, member 2 |
436 |
0.82 |
chr2_74697508_74699145 | 8.25 |
Hoxd9 |
homeobox D9 |
599 |
0.31 |
chr12_119235620_119236481 | 8.23 |
Itgb8 |
integrin beta 8 |
2720 |
0.31 |
chr2_74669164_74669486 | 8.03 |
Hoxd13 |
homeobox D13 |
1015 |
0.24 |
chr2_74713120_74713846 | 7.98 |
Hoxd3os1 |
homeobox D3, opposite strand 1 |
957 |
0.21 |
chr10_102513522_102514467 | 7.85 |
Rassf9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
1738 |
0.36 |
chr3_86545154_86545526 | 7.81 |
Lrba |
LPS-responsive beige-like anchor |
1415 |
0.43 |
chr6_52220130_52221236 | 7.80 |
Hoxa7 |
homeobox A7 |
290 |
0.69 |
chrX_133682515_133683917 | 7.77 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr15_50885475_50885991 | 7.58 |
Trps1 |
transcriptional repressor GATA binding 1 |
2927 |
0.26 |
chr2_74708305_74709012 | 7.55 |
Hoxd3 |
homeobox D3 |
3269 |
0.07 |
chr17_59421393_59421956 | 7.42 |
Gm23203 |
predicted gene, 23203 |
147991 |
0.04 |
chr6_50808388_50809281 | 7.38 |
Gm44109 |
predicted gene, 44109 |
5803 |
0.18 |
chr1_162217585_162219370 | 7.36 |
Dnm3os |
dynamin 3, opposite strand |
601 |
0.46 |
chr15_102998261_102998699 | 7.34 |
Hoxc6 |
homeobox C6 |
223 |
0.84 |
chr9_35424475_35426234 | 7.31 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
1766 |
0.31 |
chr10_119761770_119762630 | 7.22 |
Grip1os2 |
glutamate receptor interacting protein 1, opposite strand 2 |
501 |
0.84 |
chr1_163358681_163359585 | 7.18 |
Gm24940 |
predicted gene, 24940 |
43150 |
0.12 |
chr12_36315313_36316308 | 7.18 |
Sostdc1 |
sclerostin domain containing 1 |
1671 |
0.31 |
chr9_41584760_41585051 | 7.07 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2864 |
0.14 |
chr3_114033658_114034247 | 7.04 |
Col11a1 |
collagen, type XI, alpha 1 |
3318 |
0.39 |
chr2_57613916_57615034 | 7.02 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chr13_48264468_48265300 | 6.99 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
2261 |
0.19 |
chr10_99267189_99269284 | 6.97 |
Gm48089 |
predicted gene, 48089 |
340 |
0.78 |
chr9_71892666_71893902 | 6.89 |
Tcf12 |
transcription factor 12 |
2701 |
0.17 |
chr15_102950417_102951549 | 6.89 |
Hotair |
HOX transcript antisense RNA (non-protein coding) |
3253 |
0.11 |
chr11_96281341_96281893 | 6.84 |
Hoxb8 |
homeobox B8 |
288 |
0.75 |
chr12_53061586_53062872 | 6.79 |
n-R5s58 |
nuclear encoded rRNA 5S 58 |
15403 |
0.29 |
chr3_38892303_38893788 | 6.73 |
Fat4 |
FAT atypical cadherin 4 |
2103 |
0.36 |
chr8_87860974_87861490 | 6.66 |
Zfp423 |
zinc finger protein 423 |
34503 |
0.21 |
chrX_153501207_153502250 | 6.58 |
Ubqln2 |
ubiquilin 2 |
3501 |
0.22 |
chr2_32428080_32429746 | 6.58 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr2_74706316_74706960 | 6.56 |
Hoxd8 |
homeobox D8 |
1486 |
0.13 |
chr7_137303670_137304511 | 6.48 |
Ebf3 |
early B cell factor 3 |
9826 |
0.2 |
chr18_42841025_42841640 | 6.47 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
57483 |
0.14 |
chr10_97566192_97567945 | 6.42 |
Lum |
lumican |
1940 |
0.32 |
chr2_147708797_147709641 | 6.40 |
A530006G24Rik |
RIKEN cDNA A530006G24 gene |
1474 |
0.48 |
chr1_14307063_14308005 | 6.37 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
2302 |
0.39 |
chr2_169636158_169637469 | 6.29 |
Tshz2 |
teashirt zinc finger family member 2 |
3137 |
0.27 |
chr8_91948462_91949309 | 6.22 |
Gm28515 |
predicted gene 28515 |
35819 |
0.12 |
chr3_148984296_148985724 | 6.18 |
Gm43573 |
predicted gene 43573 |
4142 |
0.2 |
chr14_67236008_67239452 | 6.17 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr13_40725917_40726475 | 6.17 |
Gm26688 |
predicted gene, 26688 |
1612 |
0.22 |
chr3_83768357_83769273 | 6.16 |
Sfrp2 |
secreted frizzled-related protein 2 |
1962 |
0.31 |
chr14_122480308_122481080 | 6.15 |
Zic2 |
zinc finger protein of the cerebellum 2 |
2594 |
0.16 |
chr19_59940546_59941181 | 6.12 |
Rab11fip2 |
RAB11 family interacting protein 2 (class I) |
2137 |
0.29 |
chr11_85838795_85841602 | 6.09 |
Tbx2 |
T-box 2 |
7647 |
0.13 |
chr6_143918358_143918951 | 6.09 |
Sox5 |
SRY (sex determining region Y)-box 5 |
28434 |
0.22 |
chr10_105427351_105427877 | 6.08 |
Gm48203 |
predicted gene, 48203 |
33328 |
0.14 |
chr10_126169548_126169835 | 6.03 |
Gm4510 |
predicted gene 4510 |
16632 |
0.26 |
chr11_96291690_96292512 | 6.01 |
Hoxb6 |
homeobox B6 |
375 |
0.66 |
chr11_96321777_96323051 | 5.99 |
Hoxb3 |
homeobox B3 |
912 |
0.3 |
chr10_120882150_120883419 | 5.92 |
Msrb3 |
methionine sulfoxide reductase B3 |
11632 |
0.13 |
chr10_23449342_23450574 | 5.91 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
99172 |
0.07 |
chr13_73117045_73117937 | 5.90 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
115904 |
0.06 |
chr15_37803419_37804373 | 5.87 |
Ncald |
neurocalcin delta |
11326 |
0.17 |
chr12_29529828_29531185 | 5.82 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr11_96282910_96285155 | 5.80 |
Hoxb8 |
homeobox B8 |
1307 |
0.19 |
chr10_99353403_99354040 | 5.79 |
B530045E10Rik |
RIKEN cDNA B530045E10 gene |
49069 |
0.1 |
chr8_89108083_89108415 | 5.77 |
Gm6625 |
predicted gene 6625 |
38809 |
0.17 |
chr12_69085217_69086253 | 5.74 |
Gm47518 |
predicted gene, 47518 |
34612 |
0.08 |
chr3_131566361_131566512 | 5.72 |
Papss1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
1501 |
0.48 |
chr6_52226761_52228144 | 5.62 |
Hoxa9 |
homeobox A9 |
82 |
0.89 |
chr18_43686487_43688415 | 5.62 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr4_32530444_32532006 | 5.61 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
29720 |
0.15 |
chr3_99261050_99262399 | 5.60 |
Gm43120 |
predicted gene 43120 |
439 |
0.81 |
chr3_34331252_34332079 | 5.60 |
Gm38505 |
predicted gene, 38505 |
20047 |
0.21 |
chr10_125967796_125968797 | 5.59 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2043 |
0.45 |
chr6_52240578_52240985 | 5.55 |
Hoxa10 |
homeobox A10 |
14 |
0.91 |
chr15_13067157_13068365 | 5.54 |
Gm24664 |
predicted gene, 24664 |
86932 |
0.08 |
chr11_64438335_64439195 | 5.54 |
Hs3st3a1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
3433 |
0.37 |
chr6_94400542_94401615 | 5.53 |
Gm7825 |
predicted gene 7825 |
16751 |
0.2 |
chr7_36710059_36710756 | 5.51 |
Gm37452 |
predicted gene, 37452 |
233 |
0.9 |
chr4_98106191_98107304 | 5.51 |
Gm12691 |
predicted gene 12691 |
39852 |
0.19 |
chr4_116223265_116224130 | 5.51 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr1_42699114_42699733 | 5.49 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
3655 |
0.16 |
chr3_149705320_149706167 | 5.42 |
Gm31121 |
predicted gene, 31121 |
45347 |
0.2 |
chr6_52443203_52444062 | 5.41 |
1700094M24Rik |
RIKEN cDNA 1700094M24 gene |
48819 |
0.09 |
chr6_52222863_52223204 | 5.39 |
Hoxa7 |
homeobox A7 |
1179 |
0.17 |
chr9_10903843_10905236 | 5.37 |
Cntn5 |
contactin 5 |
90 |
0.65 |
chr16_93272287_93272901 | 5.34 |
1810053B23Rik |
RIKEN cDNA 1810053B23 gene |
80595 |
0.09 |
chr2_18042311_18043883 | 5.34 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr1_14303307_14303936 | 5.33 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
949 |
0.67 |
chr11_96277191_96278406 | 5.33 |
Hoxb8 |
homeobox B8 |
4107 |
0.08 |
chr3_66977838_66980287 | 5.29 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr6_52247829_52249819 | 5.27 |
Hoxa11os |
homeobox A11, opposite strand |
402 |
0.59 |
chr4_76445756_76446479 | 5.23 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
3863 |
0.26 |
chr2_74692311_74693685 | 5.21 |
Hoxd10 |
homeobox D10 |
1074 |
0.19 |
chr15_102936617_102937888 | 5.19 |
Hoxc12 |
homeobox C12 |
495 |
0.63 |
chr18_65583033_65584701 | 5.17 |
Zfp532 |
zinc finger protein 532 |
70 |
0.95 |
chr9_47545421_47546373 | 5.11 |
Cadm1 |
cell adhesion molecule 1 |
15524 |
0.19 |
chr13_39979317_39979823 | 5.10 |
Gm47316 |
predicted gene, 47316 |
95189 |
0.08 |
chrX_143930842_143933141 | 5.10 |
Dcx |
doublecortin |
1059 |
0.64 |
chrX_58033180_58034063 | 5.10 |
Zic3 |
zinc finger protein of the cerebellum 3 |
2611 |
0.36 |
chr15_102996247_102997185 | 5.10 |
Hoxc6 |
homeobox C6 |
1541 |
0.19 |
chr3_68283428_68284024 | 5.07 |
Gm10292 |
predicted gene 10292 |
49470 |
0.17 |
chr17_17403475_17404024 | 5.05 |
Lix1 |
limb and CNS expressed 1 |
1077 |
0.44 |
chr13_85926958_85927576 | 5.04 |
Gm46396 |
predicted gene, 46396 |
35525 |
0.19 |
chr6_52221810_52222668 | 5.04 |
Hoxa7 |
homeobox A7 |
385 |
0.58 |
chr12_107112064_107112640 | 5.04 |
Gm16086 |
predicted gene 16086 |
12679 |
0.18 |
chr14_67291186_67291756 | 5.03 |
Gm23178 |
predicted gene, 23178 |
16508 |
0.15 |
chr14_76420544_76421824 | 5.02 |
Tsc22d1 |
TSC22 domain family, member 1 |
2356 |
0.39 |
chr5_128603772_128604461 | 5.02 |
Fzd10 |
frizzled class receptor 10 |
3272 |
0.19 |
chr16_88599651_88600158 | 5.00 |
Gm49688 |
predicted gene, 49688 |
8766 |
0.11 |
chr5_67400588_67401129 | 5.00 |
Bend4 |
BEN domain containing 4 |
26472 |
0.11 |
chr3_99254836_99255604 | 5.00 |
Tbx15 |
T-box 15 |
1460 |
0.36 |
chr7_115920406_115920948 | 4.98 |
Sox6 |
SRY (sex determining region Y)-box 6 |
60825 |
0.12 |
chr14_110754559_110755226 | 4.97 |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
257 |
0.91 |
chr7_96610032_96610534 | 4.95 |
Gm15414 |
predicted gene 15414 |
18786 |
0.22 |
chr12_9578132_9580204 | 4.94 |
Osr1 |
odd-skipped related transcription factor 1 |
4727 |
0.2 |
chr8_108705555_108706511 | 4.92 |
Zfhx3 |
zinc finger homeobox 3 |
2933 |
0.32 |
chr7_130262055_130263206 | 4.91 |
Fgfr2 |
fibroblast growth factor receptor 2 |
773 |
0.75 |
chr7_66039721_66040043 | 4.91 |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
1464 |
0.3 |
chr5_119673827_119675890 | 4.91 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr7_84678794_84680323 | 4.89 |
Zfand6 |
zinc finger, AN1-type domain 6 |
162 |
0.95 |
chr1_45312046_45312607 | 4.89 |
Gm47302 |
predicted gene, 47302 |
653 |
0.46 |
chr15_103009345_103011570 | 4.88 |
Hoxc6 |
homeobox C6 |
884 |
0.35 |
chrX_21485587_21486692 | 4.85 |
Agtr2 |
angiotensin II receptor, type 2 |
1417 |
0.41 |
chr11_96297868_96298678 | 4.84 |
Hoxb6 |
homeobox B6 |
898 |
0.3 |
chr1_61301142_61302279 | 4.83 |
Gm11587 |
predicted gene 11587 |
199 |
0.95 |
chr5_13125231_13126281 | 4.82 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
163 |
0.95 |
chr2_126034531_126036034 | 4.82 |
Fgf7 |
fibroblast growth factor 7 |
309 |
0.93 |
chr7_36016816_36017552 | 4.80 |
Gm38991 |
predicted gene, 38991 |
80194 |
0.09 |
chr6_51183297_51184606 | 4.79 |
Mir148a |
microRNA 148a |
85959 |
0.08 |
chr7_71224092_71224526 | 4.78 |
6030442E23Rik |
RIKEN cDNA 6030442E23 gene |
7260 |
0.23 |
chr19_58228544_58228773 | 4.78 |
Gm16277 |
predicted gene 16277 |
24519 |
0.25 |
chr2_74694827_74695683 | 4.78 |
Gm14396 |
predicted gene 14396 |
265 |
0.7 |
chr19_18902287_18902920 | 4.78 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
61966 |
0.13 |
chr1_41034644_41035698 | 4.78 |
4930448I06Rik |
RIKEN cDNA 4930448I06 gene |
146081 |
0.04 |
chr2_51144318_51145477 | 4.77 |
Rnd3 |
Rho family GTPase 3 |
4197 |
0.29 |
chr3_31099281_31100546 | 4.76 |
Skil |
SKI-like |
3080 |
0.26 |
chr11_41999400_42000640 | 4.75 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr10_125970130_125970976 | 4.74 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4300 |
0.33 |
chr10_125967599_125967789 | 4.74 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
1441 |
0.55 |
chr2_129911174_129911836 | 4.72 |
Gm28196 |
predicted gene 28196 |
37063 |
0.15 |
chr2_116056837_116059755 | 4.68 |
Meis2 |
Meis homeobox 2 |
546 |
0.75 |
chr13_115051906_115052529 | 4.65 |
Gm10734 |
predicted gene 10734 |
37284 |
0.12 |
chr9_4794566_4795419 | 4.65 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
527 |
0.88 |
chr7_70822436_70823497 | 4.64 |
Gm42397 |
predicted gene, 42397 |
47947 |
0.14 |
chr10_125969776_125969970 | 4.62 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
3620 |
0.35 |
chr9_88068626_88069388 | 4.62 |
Gm28877 |
predicted gene 28877 |
29315 |
0.16 |
chr13_51410301_51411730 | 4.61 |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
2376 |
0.29 |
chr10_80228269_80230263 | 4.57 |
Pwwp3a |
PWWP domain containing 3A, DNA repair factor |
2515 |
0.13 |
chr8_108716860_108718878 | 4.57 |
Zfhx3 |
zinc finger homeobox 3 |
3225 |
0.3 |
chr2_109919996_109920952 | 4.56 |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
2827 |
0.25 |
chr5_111175236_111175918 | 4.55 |
Gm43677 |
predicted gene 43677 |
17266 |
0.17 |
chr11_96325013_96326405 | 4.55 |
Hoxb3 |
homeobox B3 |
2353 |
0.11 |
chr1_14308374_14310407 | 4.51 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
446 |
0.88 |
chr1_168426195_168428871 | 4.49 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr14_122477033_122477655 | 4.49 |
Zic2 |
zinc finger protein of the cerebellum 2 |
756 |
0.48 |
chr10_90432226_90432835 | 4.48 |
Gm22602 |
predicted gene, 22602 |
18380 |
0.28 |
chr18_78237492_78238595 | 4.47 |
Slc14a2 |
solute carrier family 14 (urea transporter), member 2 |
28949 |
0.22 |
chr11_88714836_88715643 | 4.47 |
Msi2 |
musashi RNA-binding protein 2 |
2862 |
0.23 |
chr8_92113966_92115066 | 4.46 |
Gm45332 |
predicted gene 45332 |
43750 |
0.13 |
chr17_30911542_30911767 | 4.46 |
Glp1r |
glucagon-like peptide 1 receptor |
9795 |
0.1 |
chr8_26595969_26596229 | 4.46 |
Gm39149 |
predicted gene, 39149 |
16297 |
0.16 |
chr18_57134532_57135579 | 4.46 |
Megf10 |
multiple EGF-like-domains 10 |
1965 |
0.32 |
chr6_53817061_53817543 | 4.45 |
Gm16499 |
predicted gene 16499 |
1441 |
0.39 |
chr6_52199825_52201748 | 4.45 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
338 |
0.63 |
chr7_137308318_137308469 | 4.44 |
Ebf3 |
early B cell factor 3 |
5523 |
0.21 |
chr15_25624832_25625841 | 4.44 |
Myo10 |
myosin X |
2787 |
0.25 |
chr3_99248252_99249856 | 4.43 |
Tbx15 |
T-box 15 |
4706 |
0.18 |
chr11_96285767_96287533 | 4.43 |
Hoxb7 |
homeobox B7 |
27 |
0.93 |
chr9_41585694_41587243 | 4.43 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr15_50884152_50885280 | 4.42 |
Trps1 |
transcriptional repressor GATA binding 1 |
1910 |
0.34 |
chr8_65036064_65036521 | 4.40 |
Gm45886 |
predicted gene 45886 |
804 |
0.33 |
chr19_58228804_58229016 | 4.39 |
Gm16277 |
predicted gene 16277 |
24771 |
0.25 |
chr13_44843445_44844028 | 4.39 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
2953 |
0.28 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 31.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
6.3 | 44.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
5.5 | 5.5 | GO:0010159 | specification of organ position(GO:0010159) |
4.7 | 14.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
4.5 | 26.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
4.4 | 8.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
4.3 | 13.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
4.2 | 16.7 | GO:0060594 | mammary gland specification(GO:0060594) |
3.6 | 17.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
3.4 | 10.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.3 | 9.8 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
3.2 | 12.9 | GO:0061205 | paramesonephric duct development(GO:0061205) |
3.2 | 6.5 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
3.2 | 9.6 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
3.1 | 40.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
3.1 | 3.1 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.1 | 9.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.8 | 11.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
2.8 | 2.8 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
2.7 | 10.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.7 | 5.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.5 | 12.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.5 | 9.9 | GO:0060023 | soft palate development(GO:0060023) |
2.4 | 7.1 | GO:0048880 | sensory system development(GO:0048880) |
2.4 | 7.1 | GO:0061550 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) facioacoustic ganglion development(GO:1903375) |
2.3 | 16.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
2.2 | 6.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.2 | 4.4 | GO:0060435 | bronchiole development(GO:0060435) |
2.2 | 4.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
2.2 | 8.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
2.2 | 6.5 | GO:0072017 | distal tubule development(GO:0072017) |
2.2 | 2.2 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
2.1 | 6.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
2.0 | 6.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
2.0 | 6.0 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.9 | 3.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.9 | 3.9 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.9 | 32.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.9 | 5.7 | GO:0060437 | lung growth(GO:0060437) |
1.9 | 5.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
1.8 | 12.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.8 | 166.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
1.8 | 3.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.7 | 5.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.7 | 3.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.7 | 3.4 | GO:0070384 | Harderian gland development(GO:0070384) |
1.6 | 8.1 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
1.6 | 9.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.6 | 4.8 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
1.6 | 3.1 | GO:0035564 | regulation of kidney size(GO:0035564) |
1.6 | 4.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.5 | 4.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.5 | 1.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.5 | 1.5 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.5 | 1.5 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.5 | 1.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.4 | 4.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.4 | 1.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.4 | 4.2 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.4 | 1.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.4 | 1.4 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
1.3 | 4.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.3 | 4.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 2.7 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.3 | 3.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 2.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.3 | 6.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.3 | 3.8 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.3 | 7.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.2 | 6.2 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.2 | 2.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.2 | 2.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
1.2 | 4.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.2 | 9.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.2 | 2.4 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.2 | 4.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.1 | 5.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.1 | 2.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.1 | 3.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.1 | 2.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.1 | 3.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.1 | 10.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
1.1 | 4.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
1.1 | 1.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.1 | 1.1 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
1.1 | 3.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
1.0 | 8.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.0 | 9.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.0 | 2.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.0 | 2.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.0 | 1.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.0 | 4.1 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.0 | 2.0 | GO:0060596 | mammary placode formation(GO:0060596) |
1.0 | 3.0 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
1.0 | 3.0 | GO:0007412 | axon target recognition(GO:0007412) |
1.0 | 2.0 | GO:1902338 | negative regulation of apoptotic process involved in morphogenesis(GO:1902338) |
1.0 | 3.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
1.0 | 2.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.0 | 1.0 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.0 | 3.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.0 | 2.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.9 | 2.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.9 | 1.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.9 | 14.9 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.9 | 1.9 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 9.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 2.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.9 | 1.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.9 | 1.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.9 | 1.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.9 | 9.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.9 | 1.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.9 | 2.6 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.8 | 2.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.8 | 2.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 0.8 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.8 | 2.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 4.1 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.8 | 1.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.8 | 0.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.8 | 2.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.8 | 0.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.8 | 1.6 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.8 | 4.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.8 | 0.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 4.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 1.6 | GO:0001757 | somite specification(GO:0001757) |
0.8 | 1.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.8 | 1.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.8 | 3.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.8 | 2.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 0.8 | GO:0035640 | exploration behavior(GO:0035640) |
0.8 | 0.8 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.7 | 0.7 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.7 | 2.9 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 0.7 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.7 | 3.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 1.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.7 | 2.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.7 | 2.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.7 | 4.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 2.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 0.7 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) |
0.7 | 3.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.7 | 3.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 3.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.7 | 2.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.7 | 0.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.7 | 1.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 0.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.7 | 4.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 2.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.7 | 0.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.7 | 2.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.7 | 2.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.7 | 7.3 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.7 | 3.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 2.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.6 | 1.9 | GO:0033504 | floor plate development(GO:0033504) |
0.6 | 5.0 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.6 | 2.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.6 | 1.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.6 | 3.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.6 | 3.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 3.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.6 | 0.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.6 | 1.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 6.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 1.2 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.6 | 2.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.6 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.6 | 3.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 1.8 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.6 | 1.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.6 | 2.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 2.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 1.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 1.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.6 | 9.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.6 | 0.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.6 | 2.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.6 | 1.7 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 2.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.5 | 2.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.5 | 2.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 0.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.5 | 1.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 1.6 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.5 | 43.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 2.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.5 | 1.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 0.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 3.5 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 0.5 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.5 | 3.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 0.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.5 | 2.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 3.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 1.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 0.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 3.5 | GO:0060026 | convergent extension(GO:0060026) |
0.5 | 1.5 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.5 | 0.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.5 | 1.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 2.9 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.5 | 2.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 2.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.5 | 1.9 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.5 | 0.9 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.5 | 0.9 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 0.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.5 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.5 | 1.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 3.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.4 | 0.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 1.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 0.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 2.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 1.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 1.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 3.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 0.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.4 | 2.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.4 | 1.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 1.3 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.4 | 2.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 4.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 3.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 1.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 0.8 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.4 | 2.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.4 | 1.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 18.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 1.6 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.4 | 6.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 1.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.4 | 0.8 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 1.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.4 | 4.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 0.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.4 | 0.8 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.4 | 25.2 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.4 | 2.3 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.4 | 4.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 1.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 1.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 0.8 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 1.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 2.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 4.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.4 | 0.7 | GO:0035989 | tendon development(GO:0035989) |
0.4 | 1.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 0.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 0.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 0.4 | GO:0031223 | auditory behavior(GO:0031223) |
0.4 | 1.8 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.4 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 0.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 1.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 0.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.4 | 1.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.4 | 1.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.4 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 0.3 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 1.4 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.3 | 0.3 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.3 | 1.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 0.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 1.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 1.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.0 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.3 | 0.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 1.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 1.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 1.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.6 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.3 | 1.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 0.3 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.3 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 2.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 1.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 0.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 1.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 0.6 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.3 | 0.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 0.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 2.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 0.6 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.3 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 0.3 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 1.8 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.3 | 0.3 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.8 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.3 | 0.9 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 3.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 0.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.3 | 0.9 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 2.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 8.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.3 | 0.3 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.3 | 1.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.3 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.3 | 0.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.3 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 1.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 3.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 0.3 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.3 | 0.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 1.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 3.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 0.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 0.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 0.3 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.3 | 0.3 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.3 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 1.3 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.3 | GO:0021779 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.3 | 0.5 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.3 | 2.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.3 | 3.7 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.3 | 0.5 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 1.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 0.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 0.5 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 0.3 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.3 | 1.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 0.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 0.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 0.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 0.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 0.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 2.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.2 | 2.0 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.2 | 0.7 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.2 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.2 | 0.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 1.9 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.2 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.2 | 1.6 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.2 | 8.0 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.2 | 0.7 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 0.2 | GO:0021548 | pons development(GO:0021548) |
0.2 | 1.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.7 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.2 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 2.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 1.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.9 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.2 | GO:0032277 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.9 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 2.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 1.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 12.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 1.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 0.4 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.2 | 0.8 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.2 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 1.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.2 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.4 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.6 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.2 | 0.4 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.4 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 0.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 0.4 | GO:0003128 | heart field specification(GO:0003128) |
0.2 | 0.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 0.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 4.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 1.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.2 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.4 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 1.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.2 | 0.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 1.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 2.1 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.2 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.6 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.2 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.9 | GO:0032196 | transposition(GO:0032196) |
0.2 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 2.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 2.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.2 | GO:1903797 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.2 | 2.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.2 | 1.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.2 | 0.4 | GO:1903332 | regulation of protein folding(GO:1903332) positive regulation of protein folding(GO:1903334) |
0.2 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 2.8 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.2 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.2 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.2 | 0.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 1.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.2 | GO:0051938 | L-glutamate import(GO:0051938) |
0.2 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 1.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 2.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.2 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.5 | GO:0071397 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.2 | 2.5 | GO:0021549 | cerebellum development(GO:0021549) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 0.5 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.2 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 1.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.5 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 1.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.2 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.8 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.2 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 0.9 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 0.5 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 1.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.5 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.2 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 2.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.3 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.1 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 1.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 2.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 1.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 2.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.6 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.4 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.1 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 1.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 1.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.4 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 0.8 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.6 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.6 | GO:0051194 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.4 | GO:0061037 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
0.1 | 0.2 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.2 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 1.0 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.5 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.9 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 1.6 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.6 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 1.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 2.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.7 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.6 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.4 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.8 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.1 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.1 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 2.2 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 1.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.2 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.3 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.5 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 1.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 1.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 1.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.6 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.4 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 1.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 2.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 1.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 1.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 1.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 1.6 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 1.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 1.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.2 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
0.1 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.1 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.2 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 1.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.0 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.5 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 4.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 0.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.3 | GO:0030540 | female genitalia development(GO:0030540) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.1 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.1 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 5.7 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.1 | 0.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.1 | 0.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 1.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 7.2 | GO:0016197 | endosomal transport(GO:0016197) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.1 | 0.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.1 | GO:0043307 | eosinophil activation(GO:0043307) regulation of eosinophil activation(GO:1902566) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 2.5 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 1.2 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.2 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.0 | 0.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.0 | 0.0 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.3 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.0 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.2 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.0 | 2.0 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.4 | GO:0042490 | mechanoreceptor differentiation(GO:0042490) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.5 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.0 | 0.0 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.0 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.0 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.9 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.0 | 0.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.0 | 0.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.0 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.0 | 0.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) regulation of ovulation(GO:0060278) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 19.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.5 | 8.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.5 | 4.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.4 | 7.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 5.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.9 | 2.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.9 | 3.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 22.6 | GO:0016235 | aggresome(GO:0016235) |
0.7 | 2.9 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 2.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.7 | 0.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.7 | 8.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.7 | 2.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 2.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.6 | 5.6 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 4.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 4.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.6 | 10.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 2.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 2.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 1.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 0.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 2.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.6 | 4.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 1.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 2.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 22.6 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.5 | 2.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.5 | 24.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 1.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.5 | 1.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 5.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.5 | 5.5 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 2.4 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 3.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 1.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 1.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 9.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 1.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 1.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 3.0 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 1.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 119.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 2.0 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 11.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 1.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 3.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 4.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 5.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.3 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 3.8 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 3.2 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 2.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 3.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 1.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 35.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 2.1 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 2.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.7 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 1.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 8.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.4 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 0.9 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 2.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 5.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 2.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 10.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 12.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 3.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 15.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 2.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 1.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 47.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 1.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 1.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 2.0 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 7.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 11.0 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.1 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 4.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 4.8 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 2.4 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 15.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 6.9 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.6 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 1.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.1 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 3.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 3.8 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 1.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 1.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.3 | 10.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.7 | 24.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.5 | 10.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.7 | 8.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.7 | 7.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.7 | 8.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.6 | 6.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.5 | 7.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.4 | 11.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.4 | 32.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.3 | 4.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.3 | 6.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.3 | 2.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.2 | 4.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.2 | 3.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.2 | 3.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.1 | 4.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 3.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.1 | 12.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.0 | 26.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.0 | 3.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.0 | 5.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.0 | 5.7 | GO:0070888 | E-box binding(GO:0070888) |
0.9 | 8.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 1.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 3.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.8 | 0.8 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.8 | 0.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 3.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.8 | 2.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 4.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 2.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 14.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 6.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.7 | 3.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.7 | 3.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.7 | 3.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.7 | 2.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.7 | 2.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 3.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 1.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 2.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 3.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 2.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 1.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.6 | 3.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.6 | 6.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 1.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 4.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 10.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.6 | 3.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 7.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 3.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 2.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 6.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 8.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 1.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 2.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 22.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.5 | 476.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.5 | 2.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.5 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 1.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 1.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 3.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.5 | 1.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 2.9 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.5 | 1.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.5 | 1.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 4.7 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.5 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 2.8 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 0.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 4.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 1.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 3.9 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.4 | 1.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 1.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 8.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 1.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 2.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 7.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 5.9 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 3.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 1.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 8.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 2.3 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.4 | 3.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 1.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 1.1 | GO:0018564 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 4.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 0.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 1.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 1.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 1.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 11.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 2.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 1.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 2.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 6.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 2.5 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 3.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.3 | 0.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 3.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 4.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 0.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 7.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 13.7 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 1.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 4.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 1.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 2.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 1.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 2.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 1.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 1.7 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 2.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 1.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 1.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 1.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 4.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 2.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 3.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 17.9 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 1.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.8 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 2.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.8 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.2 | 0.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 2.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 2.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 1.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.7 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 1.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 0.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.2 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.8 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 5.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 14.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 1.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 4.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 2.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 2.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 8.8 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 2.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.3 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.9 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 7.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 2.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 2.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 1.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.0 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 2.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 1.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 2.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 2.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 2.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.1 | 0.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 3.8 | GO:0005261 | cation channel activity(GO:0005261) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.7 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 25.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 0.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 1.3 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.4 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 5.7 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 17.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 21.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 49.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.6 | 23.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 18.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 4.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 16.6 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 2.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 5.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 2.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 8.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 8.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 2.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 5.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 4.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 7.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 5.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 7.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 3.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 9.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 31.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 9.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 1.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 6.5 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 3.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 2.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 2.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 1.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 17.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 26.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 5.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.5 | 39.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.2 | 21.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.1 | 12.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.1 | 1.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 13.9 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.8 | 0.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.7 | 2.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.7 | 2.8 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.7 | 13.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 22.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 7.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 5.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.5 | 16.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 18.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 7.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 0.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.5 | 5.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 3.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 4.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 33.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 8.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 5.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 5.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 5.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 12.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 3.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 3.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 4.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 2.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 4.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 3.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 4.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 2.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 0.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 0.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 2.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 7.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 3.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 2.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 3.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 3.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 12.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.7 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 1.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 1.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |